Suppr超能文献

哪些凝血因子会干扰一期凝血酶原时间?

Which coagulation factors interfere with the one-stage prothrombin time?

作者信息

Talstad I

机构信息

Medical Department B, Haukeland Hospital, University of Bergen, Norway.

出版信息

Haemostasis. 1993;23(1):19-25. doi: 10.1159/000216848.

Abstract

Coagulation factors that interfere with the one-stage prothrombin time (PT) were investigated. PT responded with identical activities (adequately) against coagulation factors VII or X, only half as expected against factor IX, less than expected and nonlinearly against factor II. In multiple coagulation factor deficiencies PT did not differ from factor VII, which was the most reduced coagulation factor in warfarin therapy or liver disease. PT may also be influenced by factor VII at high activities.

摘要

对干扰一步法凝血酶原时间(PT)的凝血因子进行了研究。PT对凝血因子VII或X的反应具有相同活性(充分),对因子IX的反应仅为预期的一半,对因子II的反应低于预期且呈非线性。在多种凝血因子缺乏的情况下,PT与因子VII无差异,因子VII是华法林治疗或肝病中减少最多的凝血因子。高活性的因子VII也可能影响PT。

相似文献

1
Which coagulation factors interfere with the one-stage prothrombin time?
Haemostasis. 1993;23(1):19-25. doi: 10.1159/000216848.
3
Warfarin therapy. 1.
N Engl J Med. 1970 Sep 24;283(13):691-4. doi: 10.1056/NEJM197009242831307.
4
The liver and blood coagulation: physiology and pathology.
Gastroenterology. 1972 Aug;63(2):297-320.
8
Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time.
Thromb Res. 2012 Oct;130(4):674-81. doi: 10.1016/j.thromres.2011.12.013. Epub 2012 Jan 4.

引用本文的文献

1
Prediction of the international normalized ratio and maintenance dose during the initiation of warfarin therapy.
Br J Clin Pharmacol. 1999 Jul;48(1):63-70. doi: 10.1046/j.1365-2125.1999.00967.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验